2011
DOI: 10.1002/elps.201000610
|View full text |Cite
|
Sign up to set email alerts
|

Development and validation of a capillary electrophoresis assay for the determination of the stereoisomeric purity of chloroquine enantiomers

Abstract: A stereoselective CE assay for the determination of the enantiomeric purity of (R)-(-)-chloroquine and (S)-(+)-chloroquine was developed and validated. The separations were performed in a 50.2/40 cm uncoated fused silica capillary at 20°C using a 100 mM sodium phosphate buffer, pH 2.5, containing 30 mg/mL sulfobutylether(VII)-β-cyclodextrin as background electrolyte operated at an applied voltage of -25 kV and 20°C. The detection wavelength was 225 nm. Carbamazepine was used as internal standard. The assay was… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 19 publications
(9 citation statements)
references
References 34 publications
0
9
0
Order By: Relevance
“…The application of CE in drug impurity analysis has been summarized [79,80]. Table 1 clearly reflects the general trend that CDs are by far the most widely used chiral selectors although some studies utilized other additives such as BSA [81], maltodextrin [82], (+)-18C6H4 [83], ligand exchange [84] or the chiral ionic liquid ethylcholine bis(trifluoromethylsulfonyl) Baclofen α-CD (18 mM) 0.1 M sodium borate, pH 9.9, 1% acetonitrile 2-10 μg/ml, analysis of racemic bulk drug and tablets [103] Benzimidazole derivatives Chloroquine SBE-β-CD (30 mg/ml) 100 mM sodium phosphate, pH 2.5 0.02%, analysis of laboratory sample [108] Clopidogrel Sulfated β-CD (5%) 10 mM triethylamine/phosphoric acid 0.08-0.33 μg/ml, minor enantiomer and related substances [109] Dexamphetamine HDAS-β-CD (10 mg/ml) 0.1 M sodium phosphate buffer, pH 2.5 0.06%, minor enantiomer and charged related substances [91] Dexamphetamine Sulfated β-CD (25 mg/ml), SBE-β-CD (80 mg/ml) 50 mM sodium phosphate buffer, pH 2.5 0.01-0.02%, minor enantiomer and related substances [92] Dexamphetamine Sulfated β-CD (5.5%) 1.5% SDS, 0.5% ethyl acetate, 3.5% 1-butanol, 2.5% 2-propanol and 92% 50 mM sodium phosphate buffer, pH 3.0 0.05-0.2%, minor enantiomer and related substances [93] Econazole HP-γ-CD (40 mM) 50 mM SDS in 20 mM phosphate buffer, pH 8.0…”
Section: Pharmaceutical Analysismentioning
confidence: 99%
“…The application of CE in drug impurity analysis has been summarized [79,80]. Table 1 clearly reflects the general trend that CDs are by far the most widely used chiral selectors although some studies utilized other additives such as BSA [81], maltodextrin [82], (+)-18C6H4 [83], ligand exchange [84] or the chiral ionic liquid ethylcholine bis(trifluoromethylsulfonyl) Baclofen α-CD (18 mM) 0.1 M sodium borate, pH 9.9, 1% acetonitrile 2-10 μg/ml, analysis of racemic bulk drug and tablets [103] Benzimidazole derivatives Chloroquine SBE-β-CD (30 mg/ml) 100 mM sodium phosphate, pH 2.5 0.02%, analysis of laboratory sample [108] Clopidogrel Sulfated β-CD (5%) 10 mM triethylamine/phosphoric acid 0.08-0.33 μg/ml, minor enantiomer and related substances [109] Dexamphetamine HDAS-β-CD (10 mg/ml) 0.1 M sodium phosphate buffer, pH 2.5 0.06%, minor enantiomer and charged related substances [91] Dexamphetamine Sulfated β-CD (25 mg/ml), SBE-β-CD (80 mg/ml) 50 mM sodium phosphate buffer, pH 2.5 0.01-0.02%, minor enantiomer and related substances [92] Dexamphetamine Sulfated β-CD (5.5%) 1.5% SDS, 0.5% ethyl acetate, 3.5% 1-butanol, 2.5% 2-propanol and 92% 50 mM sodium phosphate buffer, pH 3.0 0.05-0.2%, minor enantiomer and related substances [93] Econazole HP-γ-CD (40 mM) 50 mM SDS in 20 mM phosphate buffer, pH 8.0…”
Section: Pharmaceutical Analysismentioning
confidence: 99%
“…CE methods have been applied for the impurity studies of the drugs with various types of pharmacological activities such as chemotherapeutic agents , cardiovascular drugs , antithrombotics , antihistaminic drugs , corticosteroids , analgesics , anaesthetics , antidepressants , central nervous system drugs , antimuscarinics , antibiotics , antiviral drugs , and antimalarial drugs . CE methods are increasingly being viewed as an alternative and/or complement to HPLC for analysis of various types of impurities observed during the drug production or storage.…”
Section: Determination Of Impurities Of Pharmaceuticals At Various Stmentioning
confidence: 99%
“…Therefore, the quality control of chiral drugs and their products involves also the determination of the unwanted stereoisomer (distomer) in the presence of the active stereoisomer (eutomer). During the reviewed period of time, several reports were published about the application of CE for the determination of enantiomeric purity and/or single active enantiomers in bulk drugs and/or final drug formulations including levocetirizine , ( R )‐modafinil , (–)‐huperzine A , ( R )‐pramipexol , ( R )‐(–)‐chloroquine , RS 86017 , L ‐methotrexate , ( S )‐pantoprazole , and escitalopram . The content of the lipoic acid enantiomers was determined in dietary supplements .…”
Section: Recent Applications Of Ce Enantioseparationsmentioning
confidence: 99%